Robert Mercer

Renaissance Technologies’ latest 13F shows a portfolio that still carries the fingerprints of its quant DNA, even as the firm’s top ten positions lean heavily into large-cap technology. Robert Mercer’s former shop holds roughly $72.6 billion in equities, but the largest single stake, Nvidia at 1.95% of the portfolio, is modest for a fund of this size. That dispersion is the point. Renaissance is not making concentrated bets on a handful of names; it is spreading risk across hundreds of positions, with the top ten accounting for just over 12% of total assets. The sector mix is telling. Nvidia, Meta, Intel, Palantir, and CrowdStrike all appear in the top ten, giving the portfolio a pronounced AI and semiconductor tilt. But the inclusion of United Therapeutics, Exelixis, VeriSign, and Kinross Gold breaks the pattern. Those are not momentum tech names. They are cash-generative or defensive businesses that a pure growth manager would likely skip. The presence of Kinross, a gold miner, and VeriSign, a domain registry monopoly, suggests the models are hunting for uncorrelated return streams rather than thematic alignment. Recent moves are harder to parse from a single snapshot, but the portfolio’s construction implies a style that diverges from active peers. Renaissance is not trying to outguess the market on earnings calls or management guidance. It is harvesting statistical edges across a wide universe. The Nvidia stake, while the largest, is still under 2% of assets, which means the fund is not making a directional bet on AI winners. It is owning them because the models say the risk-adjusted math works. That is the difference between Renaissance and a thematic tech fund: the conviction is in the process, not the narrative.